These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25359863)

  • 1. Fractalkine promotes human monocyte survival via a reduction in oxidative stress.
    White GE; McNeill E; Channon KM; Greaves DR
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2554-62. PubMed ID: 25359863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
    Amsellem V; Abid S; Poupel L; Parpaleix A; Rodero M; Gary-Bobo G; Latiri M; Dubois-Rande JL; Lipskaia L; Combadiere C; Adnot S
    Am J Respir Cell Mol Biol; 2017 May; 56(5):597-608. PubMed ID: 28125278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human CD16+ monocytes promote a pro-atherosclerotic endothelial cell phenotype via CX3CR1-CX3CL1 interaction.
    Roy-Chowdhury E; Brauns N; Helmke A; Nordlohne J; Bräsen JH; Schmitz J; Volkmann J; Fleig SV; Kusche-Vihrog K; Haller H; von Vietinghoff S
    Cardiovasc Res; 2021 May; 117(6):1510-1522. PubMed ID: 32717023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK.
    Green SR; Han KH; Chen Y; Almazan F; Charo IF; Miller YI; Quehenberger O
    J Immunol; 2006 Jun; 176(12):7412-20. PubMed ID: 16751386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of platelet and monocyte function by the chemokine fractalkine (CX3 CL1) in cardiovascular disease.
    Flierl U; Bauersachs J; Schäfer A
    Eur J Clin Invest; 2015 Jun; 45(6):624-33. PubMed ID: 25832902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules.
    Butoi ED; Gan AM; Manduteanu I; Stan D; Calin M; Pirvulescu M; Koenen RR; Weber C; Simionescu M
    Biochim Biophys Acta; 2011 Dec; 1813(12):2026-35. PubMed ID: 21888931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemokine CX3CL1 (fractalkine) and its receptor CX3CR1: occurrence and potential role in osteoarthritis.
    Wojdasiewicz P; Poniatowski LA; Kotela A; Deszczyński J; Kotela I; Szukiewicz D
    Arch Immunol Ther Exp (Warsz); 2014 Oct; 62(5):395-403. PubMed ID: 24556958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1.
    Stolla M; Pelisek J; von Brühl ML; Schäfer A; Barocke V; Heider P; Lorenz M; Tirniceriu A; Steinhart A; Bauersachs J; Bray PF; Massberg S; Schulz C
    PLoS One; 2012; 7(8):e43572. PubMed ID: 22916279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance aggravates atherosclerosis by reducing vascular smooth muscle cell survival and increasing CX3CL1/CX3CR1 axis.
    Martínez-Hervás S; Vinué A; Núñez L; Andrés-Blasco I; Piqueras L; Real JT; Ascaso JF; Burks DJ; Sanz MJ; González-Navarro H
    Cardiovasc Res; 2014 Jul; 103(2):324-36. PubMed ID: 24788416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-1 antitrypsin inhibits fractalkine-mediated monocyte-lung endothelial cell interactions.
    Mikosz A; Ni K; Gally F; Pratte KA; Winfree S; Lin Q; Echelman I; Wetmore B; Cao D; Justice MJ; Sandhaus RA; Maier L; Strange C; Bowler RP; Petrache I; Serban KA
    Am J Physiol Lung Cell Mol Physiol; 2023 Dec; 325(6):L711-L725. PubMed ID: 37814796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.
    Combadière C; Potteaux S; Gao JL; Esposito B; Casanova S; Lee EJ; Debré P; Tedgui A; Murphy PM; Mallat Z
    Circulation; 2003 Feb; 107(7):1009-16. PubMed ID: 12600915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The homozygous CX3CR1-M280 mutation impairs human monocyte survival.
    Collar AL; Swamydas M; O'Hayre M; Sajib MS; Hoffman KW; Singh SP; Mourad A; Johnson MD; Ferre EM; Farber JM; Lim JK; Mikelis CM; Gutkind JS; Lionakis MS
    JCI Insight; 2018 Feb; 3(3):. PubMed ID: 29415879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractalkine induces angiogenic potential in CX3CR1-expressing monocytes.
    Park Y; Lee J; Kwak JY; Noh K; Yim E; Kim HK; Kim YJ; Broxmeyer HE; Kim JA
    J Leukoc Biol; 2018 Jan; 103(1):53-66. PubMed ID: 28978662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractalkine is a novel human adipochemokine associated with type 2 diabetes.
    Shah R; Hinkle CC; Ferguson JF; Mehta NN; Li M; Qu L; Lu Y; Putt ME; Ahima RS; Reilly MP
    Diabetes; 2011 May; 60(5):1512-8. PubMed ID: 21525510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CX3CL1/fractalkine regulates the differentiation of human peripheral blood monocytes and monocyte-derived dendritic cells into osteoclasts.
    Muraoka S; Kaneko K; Motomura K; Nishio J; Nanki T
    Cytokine; 2021 Oct; 146():155652. PubMed ID: 34325117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peptide fragments of chemokine domain of fractalkine: effect on human monocyte migration].
    Kukhtina NB; Aref'eva TI; Ruleva NIu; Sidorova MV; Az'muko AA; Bespalova ZhD; Krasnikova TL
    Bioorg Khim; 2012; 38(6):660-6. PubMed ID: 23547469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation.
    Bjerkeli V; Damås JK; Fevang B; Holter JC; Aukrust P; Frøland SS
    Rheumatology (Oxford); 2007 Sep; 46(9):1422-7. PubMed ID: 17616549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways.
    Gan AM; Butoi ED; Manea A; Simion V; Stan D; Parvulescu MM; Calin M; Manduteanu I; Simionescu M
    Cell Tissue Res; 2013 Jan; 351(1):161-74. PubMed ID: 23086480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression.
    Zhang H; Guo C; Wu D; Zhang A; Gu T; Wang L; Wang C
    PLoS One; 2012; 7(7):e41147. PubMed ID: 22815945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gas6 Promotes Inflammatory (CCR2
    Laurance S; Bertin FR; Ebrahimian T; Kassim Y; Rys RN; Lehoux S; Lemarié CA; Blostein MD
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1315-1322. PubMed ID: 28450294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.